• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮卵圆孔未闭封堵术在卒中二级预防中的登记研究。

Registry of Percutaneous Closure of Patent Foramen Ovale in the Secondary Prevention of Stroke.

机构信息

Hospital de Clínicas de Porto Alegre - Universidade Federal do Rio Grande do Sul, Porto Alegre, RS - Brasil.

Instituto de Cardiologia - Fundação Universitária de Cardiologia, Porto Alegre, RS - Brasil.

出版信息

Arq Bras Cardiol. 2024 Sep;121(5):e20230293. doi: 10.36660/abc.20230293.

DOI:10.36660/abc.20230293
PMID:39417487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081132/
Abstract

BACKGROUND

The foramen ovale remains patent in about 25% of the adult population. In adult life, thrombi form in the venous circulation and can cross the interatrial septum and trigger an ischemic stroke - called paradoxical embolism. The treatment can be performed through percutaneous closure of the patent foramen ovale (PFO), but still rarely performed in Brazil because it is not available in the public health care.

OBJECTIVES

To evaluate the reproducibility of clinical trial results in real-life studies due to the low number of records published about the topic.

METHODS

This study is a retrospective cohort study including 121 patients who underwent percutaneous PFO closure for secondary prophylaxis of ischemic stroke between January 2012 and June 2022.

RESULTS

We observed a mean age of 50.3 years and most females . Severe interatrial shunt was observed in 82.6% and the presence of atrial septal aneurysm in 84.2%. After 6 months of the procedure, no patient still had a residual shunt. There were no serious bleeding or vascular complications. Recurrence of a new cerebrovascular event occurred in 1.6% of patients.

CONCLUSION

We observed a low recurrence of new ischemic neurological events and lack major complications related to the procedure.

摘要

背景

卵圆孔未闭在约 25%的成年人群中仍然存在。在成年期,静脉循环中会形成血栓,这些血栓可以穿过房间隔并引发缺血性中风,即反常栓塞。治疗方法可以通过经皮卵圆孔未闭(PFO)封堵来进行,但在巴西仍很少实施,因为公共医疗保健系统中没有这种方法。

目的

由于关于该主题的记录数量较少,评估真实世界研究中临床试验结果的重现性。

方法

本研究是一项回顾性队列研究,共纳入 121 例于 2012 年 1 月至 2022 年 6 月期间因缺血性中风二级预防而行经皮 PFO 封堵术的患者。

结果

我们观察到平均年龄为 50.3 岁,大多数为女性。82.6%的患者存在严重的房间隔分流,84.2%的患者存在房间隔瘤。术后 6 个月,无患者仍存在残余分流。无严重出血或血管并发症。新发脑血管事件的复发率为 1.6%。

结论

我们观察到新发缺血性神经事件的复发率较低,且与该手术相关的严重并发症罕见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/fb11b8148aa6/0066-782X-abc-121-05-e20230293-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/bbd2c1a40140/0066-782X-abc-121-05-e20230293-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/f02f6167c760/0066-782X-abc-121-05-e20230293-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/2f181262c38b/0066-782X-abc-121-05-e20230293-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/fb11b8148aa6/0066-782X-abc-121-05-e20230293-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/bbd2c1a40140/0066-782X-abc-121-05-e20230293-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/f02f6167c760/0066-782X-abc-121-05-e20230293-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/2f181262c38b/0066-782X-abc-121-05-e20230293-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11081132/fb11b8148aa6/0066-782X-abc-121-05-e20230293-gf02-en.jpg

相似文献

1
Registry of Percutaneous Closure of Patent Foramen Ovale in the Secondary Prevention of Stroke.经皮卵圆孔未闭封堵术在卒中二级预防中的登记研究。
Arq Bras Cardiol. 2024 Sep;121(5):e20230293. doi: 10.36660/abc.20230293.
2
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.CLOSURE I(评价 STARFlex 间隔封堵系统在因推测性反常栓塞引起的脑卒中和/或短暂性脑缺血发作的卵圆孔未闭患者中的应用)试验中,不明原因卒中合并卵圆孔未闭患者复发性事件的预测因素。
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
3
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla Flex II Occluder.使用Occlutech Figulla Flex II封堵器经介入治疗卵圆孔未闭的中期结果。
BMC Cardiovasc Disord. 2016 Nov 10;16(1):217. doi: 10.1186/s12872-016-0391-3.
4
Importance of Persistent Right-to-Left Shunt After Patent Foramen Ovale Closure in Cryptogenic Stroke Patients.卵圆孔未闭封堵术后持续性右向左分流对隐源性卒中患者的重要性。
Tex Heart Inst J. 2020 Aug 1;47(4):244-249. doi: 10.14503/THIJ-17-6582.
5
The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.《隐源性卒中后选择性卵圆孔未闭封堵的病例》
Circ Cardiovasc Interv. 2018 Mar;11(3):e004152. doi: 10.1161/CIRCINTERVENTIONS.117.004152.
6
Persistence of residual shunt at 6 and 12 months after transoesophageal echocardiography-guided percutaneous closure of a patent foramen ovale for cryptogenic stroke.经胸超声心动图引导下经皮卵圆孔未闭封堵术治疗隐源性卒中后 6 个月和 12 个月残余分流的持续存在。
Heart. 2024 Sep 16;110(19):1172-1179. doi: 10.1136/heartjnl-2024-323905.
7
Percutaneous Patent Foramen Ovale Closure: Stroke and Beyond.经皮卵圆孔未闭封堵术:卒中及其他。
Curr Cardiol Rev. 2024;20(3):77-86. doi: 10.2174/011573403X276984240304044109.
8
Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).基于倾向评分的隐源性卒中合并卵圆孔未闭患者经皮封堵与药物治疗的分析:IPSYS注册研究(意大利青年成人卒中项目)
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003470.
9
Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.隐源性卒中后卵圆孔未闭封堵术或药物治疗的长期结局:一项随机试验的荟萃分析
Catheter Cardiovasc Interv. 2018 Jul;92(1):176-186. doi: 10.1002/ccd.27636. Epub 2018 May 4.
10
Cost-Effectiveness Analysis of Percutaneous Patent Foramen Ovale Closure Preventing Secondary Ischemic Stroke in Japan.日本经皮卵圆孔未闭封堵预防继发性缺血性卒中的成本效果分析。
J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105884. doi: 10.1016/j.jstrokecerebrovasdis.2021.105884. Epub 2021 Jun 18.

本文引用的文献

1
Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.对随机试验中设备闭合卒中后卵圆孔未闭的个体患者数据进行汇总分析,发现治疗效果存在异质性。
JAMA. 2021 Dec 14;326(22):2277-2286. doi: 10.1001/jama.2021.20956.
2
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990—2019年全球、区域和国家的卒中负担及其风险因素:全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
3
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.
《2021年卒中与短暂性脑缺血发作患者卒中预防指南:美国心脏协会/美国卒中协会指南》
Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.
4
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure.经皮卵圆孔未闭封堵术后真实世界研究队列的长期随访结局。
Turk Kardiyol Dern Ars. 2021 Jan;49(1):29-39. doi: 10.5543/tkda.2020.06699.
5
Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.卵圆孔未闭封堵术获益相关的矛盾栓塞风险(RoPE)估计归因分数分析:3 项试验。
Stroke. 2020 Oct;51(10):3119-3123. doi: 10.1161/STROKEAHA.120.029350. Epub 2020 Sep 14.
6
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline.卵圆孔未闭封堵术、单独使用抗血小板治疗或抗凝治疗用于隐源性卒中的管理?一项临床实践指南。
BMJ. 2018 Jul 25;362:k2515. doi: 10.1136/bmj.k2515.
7
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.利伐沙班预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.
8
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.卵圆孔未闭封堵与卒中后抗凝或抗血小板治疗的比较
N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915.
9
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.卵圆孔未闭封堵或卒中后药物治疗的长期结局。
N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.
10
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.卵圆孔未闭封堵或抗血小板治疗不明原因卒中。
N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404.